• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Blog
  • News & Events
  • Videos
  • Resources
main-logo-small

Compliance Architects

Consulting Technology Outsourcing

  • About Us
    • Senior Staff
    • Why Us
    • Mission And Vision
    • Clients
    • Partners
    • Career Opportunities
  • Services
    • Inspection Readiness & Enforcement
      • FDA Inspection Readiness
      • Audits & Assessments
      • FDA Enforcement Response/Remediation
    • FDA Quality Consulting
      • Quality System & Compliance Turnarounds / Restructuring
      • Training / Coaching
      • Quality & Compliance Computer-Based Systems
      • External Supply Chain Compliance
      • Part 11 & Computer Systems Validation
      • Turnkey Quality Systems
    • Quality Assurance and Engineering
      • CRPN Quality Roadmap®
      • Quality Culture Assessment
      • Product Quality Consulting
      • Operational Efficiency/Compliance Effectiveness
      • Project/Program Management
    • Corporate Compliance and Litigation
      • Corporate Compliance Programs
      • Interactions With Department Of Justice And The Courts
    • FDA Regulatory Consultants
      • Product Development / Submissions / Commercialization
      • REMS (Risk Evaluation And Mitigation Strategies)
      • Mergers / Acquisitions / Licensing
    • Quality, Compliance, Regulatory & Operations’ Staffing
      • Staffing
      • Talent Management
      • Rapid Turnaround
  • Innovative Solutions
    • Writing for Compliance®
    • CRPN Quality Roadmap®
    • Quality Pulse®
    • IEEP
    • REMS
  • Success Stories
  • Industries
    • Biopharmaceuticals
    • Cannabis/CBD
    • Cell & Gene Therapies
    • Combination Products
    • Cosmetics
    • Dietary Supplements
    • Medical Devices and Diagnostics
    • Pharmaceuticals
  • Contact Us
fda quality culture example|

Visualizing Quality Culture Data – Analyzing Two Quality Culture Scenarios

Now let’s look at a third quality culture scenario, where you have a weak or ambiguous culture. Notice in this one that expressed values is a relatively low score, as is underlying assumptions. But you have very strong systems here, or at least operational systems. This is a situation where your mission and vision and values of the organization with respect to quality are not clearly differentiated. People are tentative. People are guarded. Some people call this fox-holing. You don’t want to stick your neck out because you don’t want to get it cut off, because you don’t know what the organization is going to value speaking up on a given instance.

This very often happens in a post-acquisition or a post-merger environment, where you have two companies who are trying to combine their cultures, and individuals operating in that that don’t know which culture is prevalent. And then they are afraid, in those cases. It can also happen where you have a change of senior operations or senior quality leadership. What’s the new leader bringing to the table? So people are more reserved in expressing themselves. They don’t know what—they haven’t seen the new leader operate so they don’t know what the underlying assumptions are. So they’re more reserved in those cases. Or the more toxic of this is where you have direct conflicts. You have the senior leaders, often who are well-established in their organizations, have gravitas or have some degree of historical reputational power in the organization. That established individual is in direct conflict with another individual in the organization, so it causes people to go underground.

Independent of your structures and systems, this can be a very toxic situation. It creates a very significant organizational tipping point at which your risk and those inspectional product quality business risks really become very significant in this case. This is a case that often leads, if it goes the wrong way on that tipping point, into warning letters and/or consent decrees. I had a remediated decree in one of my prior lives, and had to deal with warning letters. This is often the scenario that would drive that. Not that it can’t be remediated. It is a very moderate to high degree of difficulty to remediate, and it requires having the difficult conversation and being willing to face up that, yes, I have this conflict. Or no, we haven’t done a great job of consolidating leadership in a merged company. It has to be demonstrative leadership at the highest level over an extended period of time. You have to involve employees using some of Kotter’s methods to bring that guiding coalition forward on employee involvement, and have very clear communications that this is the way forward and then walk that talk over an extended period of time.

And then finally, the example of these culture scenarios is “not walking the talk.” This is one where you’ve got the posters on the wall that clearly show your expressed values, it’s just that people don’t believe what it says because they see something different. Or what is expected is not what’s rewarded. This is often seen where you have conflict. We mentioned the other conflict before where it was these scores were low on both of them. This is the case where you’re saying one thing but you’re not doing it. So you can have someone actually saying quality is important, but that conflict is resulting in it not being done, independent of how strong your systems are. That’s the example of decision authority or the role of the quality unit. Teresa mentioned the role of the quality unit being particularly important in the FDA’s view, on the earlier slides. If you have conflicts between departments, and we talked about that in the previous slide, why is it schedule versus quality? That’s one where this is particularly sensitive.

And then governance and policy is an interesting one here, because governance and policy—governance is the assignment of responsibility of who makes the decisions and what circumstance. Policy is the guiding principles that direct you in those times of uncertainty, to where you’re doing things consistently under times of stress. If you have an ambiguous policy that has so much wiggle room it doesn’t really give you any guidance, you may say you have a policy, but the policy is so weak that you can’t really enforce it, or it doesn’t add any value, or it doesn’t give you any guidance, useful guidance here. You have governance here of who makes the decisions. Or your governance is ambiguous and it creates conflicts because who is making the decision in this circumstance is not defined. So it results in conflict. Governance can be your friend in those cases, knowing that under these circumstances, this organization, this role has the responsibility to make this decision. So those are some important roles around governance and policy that can really set you up to succeed in those times of ambiguity.

This presents some real significant risks, not only product quality and delivery and compliance because you have this conflict here. On a daily basis, transactions may start to suffer. You may not get the actual batches out the door because that conflict is going to start rearing its head at that release decision. It presents significant inspectional risk during a regulatory inspection, because once that action that’s subject to inspections, such as a deviation investigation or a CAPA report or a change control, once you start pulling those strings on a special piece and you start seeing that they’re tied together because things are not being done the way you say they’re going to be done, that escalates it into a much deeper level of regulatory risk.

In these cases, what’s particularly noteworthy about this one, and then I’m going to hand it over to Teresa, is that if you have strong systems and structures, particularly your QMS remediations, if you’re having this type of culture and you try to fix it by going in and doing systems and QMS remediations, you’re going to have marginal impact on improving the risk reduction. That is the crux of the FDA slide number one. That you can repair these systems and structures, but if you have an unhealthy aspect on this expressed values underlying assumptions piece, it’s not going to impact your desired business outcomes. That’s the crux of all of this discussion.

Transcript taken from June 15th Webinar – “Create a Quality Culture to Aid Risk Management: Dynamic Behaviors that Achieve Quality and Business Objectives”

Filed Under: Achieving Compliance, Quality Culture

Primary Sidebar

Sign Up To Our Newsletter

You May Also Like

Proud to be a Silver Sponsor of RIC’s Inaugural Annual Meeting! Join us March 22-23, 2023 at Convene in Arlington, VA!

Compliance Architects is proud to be Silver Sponsor of this year's RIC's inaugural annual meeting! The REMS Industry Consortium fosters collaboration and innovation to advance

Join the Team at Compliance Architects as our Content Marketing Manager!

This excellent opportunity will require the successful candidate to lead the technical content marketing and marketing automation activities as well as enable, manage, and drive
life sciences staffing

Talk to us about current talent trends, and what the industry will need in the next 5 to 10 years?

Transcript taken from 2022 PMWS by Executive Platforms The talent crisis as it has been called is certainly not something that has gone away or

Footer

Compliance Architects®

  • Contact Us
  • (888) 734-9778
  • info@compliancearchitects.com

Quick Links

  • About Us
    • Senior Staff
    • Why Us
    • Mission And Vision
    • Clients
    • Partners
    • Career Opportunities
  • Services
    • Inspection Readiness & Enforcement
      • FDA Inspection Readiness
      • Audits & Assessments
      • FDA Enforcement Response/Remediation
    • FDA Quality Consulting
      • Quality System & Compliance Turnarounds / Restructuring
      • Training / Coaching
      • Quality & Compliance Computer-Based Systems
      • External Supply Chain Compliance
      • Part 11 & Computer Systems Validation
      • Turnkey Quality Systems
    • Quality Assurance and Engineering
      • CRPN Quality Roadmap®
      • Quality Culture Assessment
      • Product Quality Consulting
      • Operational Efficiency/Compliance Effectiveness
      • Project/Program Management
    • Corporate Compliance and Litigation
      • Corporate Compliance Programs
      • Interactions With Department Of Justice And The Courts
    • FDA Regulatory Consultants
      • Product Development / Submissions / Commercialization
      • REMS (Risk Evaluation And Mitigation Strategies)
      • Mergers / Acquisitions / Licensing
    • Quality, Compliance, Regulatory & Operations’ Staffing
      • Staffing
      • Talent Management
      • Rapid Turnaround
  • Innovative Solutions
    • Writing for Compliance®
    • CRPN Quality Roadmap®
    • Quality Pulse®
    • IEEP
    • REMS
  • Success Stories
  • Industries
    • Biopharmaceuticals
    • Cannabis/CBD
    • Cell & Gene Therapies
    • Combination Products
    • Cosmetics
    • Dietary Supplements
    • Medical Devices and Diagnostics
    • Pharmaceuticals
  • Contact Us

Our Services

  • Inspection Readiness & Enforcement
  • FDA Quality Consulting – Systems and Training
  • Quality Assurance and Engineering
  • Corporate Compliance and Litigation Services
  • FDA Regulatory Consultants – Due Diligence
  • Quality, Compliance, Regulatory & Operations’ Staffing Services

Proprietary Solutions

  • Writing for Compliance®
  • Quality Pulse®
  • CRPN Quality Roadmap®

© 2009-2023 Compliance Architects Holdings LLC – used by permission. All copyrights, trademarks and other intellectual property are the property of Compliance Architects Holdings LLC and are used by permission.

  • Debarment Certification Statement
  • Privacy Policy
  • Terms of Use

Contact Us Today

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT